Management provided a 2026 adjusted total revenue target of $230 million to $270 million, including $35 million to $45 million of Nuvaxovid product sales under existing orders, $40 million to $50 ...
NORTHAMPTON, MA / ACCESS Newswire / April 28, 2026 / Direct Relief and The Pfizer Foundation today announced the third cohort of the Innovation Awards in Community Health, supporting infectious ...
RNA rewards companies that can integrate biology, data science, manufacturing, and clinical development into a single ...
The MarketWatch News Department was not involved in the creation of this content. Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research ...
Pfizer Inc. (NYSE:PFE) ranks among the top picks for a retirement portfolio. BMO Capital reaffirmed its Outperform rating and $30 price target for Pfizer Inc. (NYSE:PFE) on September 23 in response to ...
AbbVie (NYSE:ABBV) and Pfizer (NYSE:PFE) both reported fourth quarter earnings in early February. AbbVie posted record net ...
Repertoire and Pioneering Medicines, Flagship's in-house drug development unit, will jointly conduct research activities leveraging Repertoire's DECODE™ platform CAMBRIDGE, Mass., Dec. 22, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results